Pmbi/drug/ltd. 228/2026

Work Description - Limited E-tender For The Supply Of Drug Code-217 (ranitidine Tablets Ip 150 Mg) To Pmbi

The Bureau of Pharma PSUs of India (BPPI), operating as a Central Government Ministry/Department, invites bids for a Limited e-Tender, identified by Tender ID 2026_BPPI_912900_1 and Tender Reference Number PMBI/DRUG/LTD.-228/2026. This tender seeks the supply of Drug Code-217, specifically Ranitidine Tablets IP 150 mg, to PMBI. The procurement falls under the Goods category, with a focus on Drugs and Pharmaceutical Products, and is structured as an Item Rate contract. Key dates for this tender include its e-publication on 12-Jun-2026 at 06:05 PM. Bidders can download tender documents from 12-Jun-2026 at 06:05 PM until 19-Jun-2026 at 05:00 PM. The bid submission period commences on 13-Jun-2026 at 12:00 PM and concludes on 19-Jun-2026 at 05:00 PM. Clarifications can be sought from 12-Jun-2026 06:05 PM until 16-Jun-2026 05:00 PM. The technical bids will be opened on 24-Jun-2026 at 04:30 PM. The estimated Tender Value for this contract is ₹50,00,000. Bidders are required to submit an Earnest Money Deposit (EMD) of ₹1,00,000, payable to the Office of PMBI at Delhi. EMD exemption is allowed, and payment can be made via Demand Draft, RTGS, NEFT, Bankers Cheque, or Bank Guarantee. Notably, there is no Tender Fee applicable for this procurement. The bidding process involves two covers: one for Fee/Pre-qualification/Technical details and another for Finance, both requiring submission in PDF format, with the BOQ in XLS format. The anticipated period of work is 30 days, and bids will remain valid for 60 days from the bid opening date. Further details, including specific addresses for submissions and bid opening, are as per the comprehensive tender document.